Amid the rising number of Covid-19 cases across the country, Serum Institute of India (SII) is going to restart the manufacturing of Covishield vaccines. The CEO OF SII, Adar Poonawalla, announced that "6-7 million doses available in 90 days". COVID-19 Surge in India: Coronavirus Moving Towards Endemic Stage, Cases May Rise for Next 10-12 Days.

Covidshield Vaccine Production Steadfast

(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter (X), Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)